Greenwich Stock Probability of Future Stock Price Finishing Over 59.35

GLSI
 Stock
  

USD 8.96  0.49  5.79%   

Greenwich Lifesciences' future price is the expected price of Greenwich Lifesciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Greenwich Lifesciences performance during a given time horizon utilizing its historical volatility. The current Price to Book Value is estimated to increase to 12.11, while Price to Earnings Ratio are projected to decrease to (75.00) .
  
Refresh
Please check Greenwich Lifesciences Backtesting, Greenwich Lifesciences Valuation, Greenwich Lifesciences Correlation, Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Volatility, Greenwich Lifesciences History as well as Greenwich Lifesciences Performance. Please specify Greenwich Lifesciences time horizon, a valid symbol (red box) and a target price (blue box) you would like Greenwich Lifesciences odds to be computed.
Apply Odds

Greenwich Lifesciences Target Price Odds to finish over 59.35

The tendency of Greenwich Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 59.35  or more in 90 days
 8.96 90 days 59.35  close to zero percent
Based on a normal probability distribution, the odds of Greenwich Lifesciences to move over $ 59.35  or more in 90 days from now is close to zero percent (This Greenwich Lifesciences probability density function shows the probability of Greenwich Stock to fall within a particular range of prices over 90 days) . Probability of Greenwich Lifesciences price to stay between its current price of $ 8.96  and $ 59.35  at the end of the 90-day period is about 74.41 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.45 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Greenwich Lifesciences will likely underperform. Additionally The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Greenwich Lifesciences is significantly underperforming DOW.
 Greenwich Lifesciences Price Density 
      Price 

Predictive Modules for Greenwich Lifesciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Greenwich Lifesciences. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Greenwich Lifesciences in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
2.118.7215.33
Details
Intrinsic
Valuation
LowReal ValueHigh
8.0626.1332.74
Details
Naive
Forecast
LowNext ValueHigh
2.969.5716.17
Details
1 Analysts
Consensus
LowTarget PriceHigh
78.0078.0078.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Greenwich Lifesciences. Your research has to be compared to or analyzed against Greenwich Lifesciences' peers to derive any actionable benefits. When done correctly, Greenwich Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Greenwich Lifesciences.

Greenwich Lifesciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Greenwich Lifesciences is not an exception. The market had few large corrections towards the Greenwich Lifesciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Greenwich Lifesciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Greenwich Lifesciences within the framework of very fundamental risk indicators.
α
Alpha over DOW
-0.64
β
Beta against DOW1.45
σ
Overall volatility
4.33
Ir
Information ratio -0.11

Greenwich Lifesciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Greenwich Lifesciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Greenwich Lifesciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Greenwich Lifesciences generated a negative expected return over the last 90 days
Greenwich Lifesciences has high historical volatility and very poor performance
Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.57 M).
Greenwich Lifesciences currently holds about 27.2 M in cash with (4.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures
Roughly 78.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Purchase by Patel Snehal of 6465 shares of Greenwich Lifesciences

Greenwich Lifesciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Greenwich Stock often depends not only on the future outlook of the current and potential Greenwich Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Greenwich Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.30%
Short Percent Of Float8.01%
Float Shares2.9M
Shares Short Prior Month319.52k
Average Daily Volume Last 10 Day167.77k
Average Daily Volume In Three Month141.24k
Date Short Interest29th of April 2022

Greenwich Lifesciences Technical Analysis

Greenwich Lifesciences' future price can be derived by breaking down and analyzing its technical indicators over time. Greenwich Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Greenwich Lifesciences. In general, you should focus on analyzing Greenwich Stock price patterns and their correlations with different microeconomic environments and drivers.

Greenwich Lifesciences Predictive Forecast Models

Greenwich Lifesciences time-series forecasting models is one of many Greenwich Lifesciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Greenwich Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Greenwich Lifesciences

Checking the ongoing alerts about Greenwich Lifesciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Greenwich Lifesciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Greenwich Lifesciences Alerts

Greenwich Lifesciences Alerts and Suggestions

Greenwich Lifesciences generated a negative expected return over the last 90 days
Greenwich Lifesciences has high historical volatility and very poor performance
Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.57 M).
Greenwich Lifesciences currently holds about 27.2 M in cash with (4.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures
Roughly 78.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Purchase by Patel Snehal of 6465 shares of Greenwich Lifesciences
Please check Greenwich Lifesciences Backtesting, Greenwich Lifesciences Valuation, Greenwich Lifesciences Correlation, Greenwich Lifesciences Hype Analysis, Greenwich Lifesciences Volatility, Greenwich Lifesciences History as well as Greenwich Lifesciences Performance. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
116.5 M
Return On Assets
-0.15
Return On Equity
-0.24
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.